Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study

Documenti analoghi

• An artificial intelligence‐driven scoring system to measure histological disease activity in ulcerative colitis
  di: Laurent Peyrin‐Biroulet, et al.
  Pubblicazione: (2024)
• Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
  di: Shintaro Akiyama, et al.
  Pubblicazione: (2024)
• High Incidence of Metachronous Lesions After Endoscopic Removal in Patients With Ulcerative Colitis: Results of a Long‐Term Follow‐Up in Multicenter Registry Study
  di: Shunichi Yanai, et al.
  Pubblicazione: (2026)
• Capsule Endoscopy in Inflammatory Bowel Disease: Current Status and Issues in Clinical Practice
  di: Teppei Omori, et al.
  Pubblicazione: (2025)
• Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing
  di: Tomohiro Fukuda, et al.
  Pubblicazione: (2024)